Capital Group Investment Management Pte. Ltd.
Source: SEC Form 13F · as of Mar 2026Capital Group Investment Management Pte. Ltd. holds 16 biotech & pharma companies tracked by BioSniper, totaling $70.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$70.9M
| Company | Shares | Value |
|---|---|---|
| AZNASTRAZENECA PLC | 99,013 | $19.3M |
| LLYELI LILLY & Co | 15,452 | $14.2M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 21,084 | $9.4M |
| RPRXRoyalty Pharma plc | 124,024 | $5.9M |
| ONCBeOne Medicines Ltd. | 16,688 | $5.0M |
| ABTABBOTT LABORATORIES | 29,663 | $3.0M |
| PFEPFIZER INC | 91,660 | $2.6M |
| REGNREGENERON PHARMACEUTICALS, INC. | 2,938 | $2.3M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 6,474 | $2.1M |
| AMGNAMGEN INC | 5,951 | $2.1M |
| ABBVAbbVie Inc. | 8,899 | $1.9M |
| BMYBRISTOL MYERS SQUIBB CO | 13,127 | $796K |
| GRFSGrifols S.A. | 81,955 | $657K |
| ICLRICON plc | 5,332 | $590K |
| CRSPCRISPR Therapeutics AG | 11,707 | $557K |
| ZBHZimmer Biomet Holdings Inc. | 4,777 | $432K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.